Applied Immune Technologies' Other Investors

Applied Immune Technologies raised a round of funding on , . Investors include OrbiMed Advisors.

Applied Immune Technologies (AIT) is a drug development company specializing in T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for a variety of therapeutic …

Articles about Applied Immune Technologies' Other Investors: